125 related articles for article (PubMed ID: 29434834)
1. Prognostic value of SPARCL1 in patients with colorectal cancer.
Han W; Cao F; Ding W; Gao XJ; Chen F; Hu YW; Ding HZ
Oncol Lett; 2018 Feb; 15(2):1429-1434. PubMed ID: 29434834
[TBL] [Abstract][Full Text] [Related]
2. Secreted protein acidic and rich in cysteines-like 1 suppresses aggressiveness and predicts better survival in colorectal cancers.
Hu H; Zhang H; Ge W; Liu X; Loera S; Chu P; Chen H; Peng J; Zhou L; Yu S; Yuan Y; Zhang S; Lai L; Yen Y; Zheng S
Clin Cancer Res; 2012 Oct; 18(19):5438-48. PubMed ID: 22891198
[TBL] [Abstract][Full Text] [Related]
3. Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer.
Li P; Qian J; Yu G; Chen Y; Liu K; Li J; Wang J
J Surg Oncol; 2012 Jan; 105(1):31-7. PubMed ID: 22161898
[TBL] [Abstract][Full Text] [Related]
4. Secreted protein acidic and rich in cysteine-like 1 suppresses metastasis in gastric stromal tumors.
Shen C; Yin Y; Chen H; Wang R; Yin X; Cai Z; Zhang B; Chen Z; Zhou Z
BMC Gastroenterol; 2018 Jul; 18(1):105. PubMed ID: 29973149
[TBL] [Abstract][Full Text] [Related]
5. SPARCL1: a potential molecule associated with tumor diagnosis, progression and prognosis of colorectal cancer.
Zhang H; Widegren E; Wang DW; Sun XF
Tumour Biol; 2011 Dec; 32(6):1225-31. PubMed ID: 21887554
[TBL] [Abstract][Full Text] [Related]
6. SPARCL1 expression increases with preoperative radiation therapy and predicts better survival in rectal cancer patients.
Kotti A; Holmqvist A; Albertsson M; Sun XF
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1196-202. PubMed ID: 24661672
[TBL] [Abstract][Full Text] [Related]
7. SPARCL1, Shp2, MSH2, E-cadherin, p53, ADCY-2 and MAPK are prognosis-related in colorectal cancer.
Yu SJ; Yu JK; Ge WT; Hu HG; Yuan Y; Zheng S
World J Gastroenterol; 2011 Apr; 17(15):2028-36. PubMed ID: 21528083
[TBL] [Abstract][Full Text] [Related]
8. Associations of tumor suppressor SPARCL1 with cancer progression and prognosis.
Li T; Liu X; Yang A; Fu W; Yin F; Zeng X
Oncol Lett; 2017 Sep; 14(3):2603-2610. PubMed ID: 28927026
[TBL] [Abstract][Full Text] [Related]
9. SPARCL1, a Novel Prognostic Predictive Factor for GI Malignancies: a Meta-Analysis.
Hu H; Cai W; Zheng S; Ge W
Cell Physiol Biochem; 2017; 44(4):1485-1496. PubMed ID: 29190626
[TBL] [Abstract][Full Text] [Related]
10. Expression of SPARC like protein 1 (SPARCL1), extracellular matrix-associated protein is down regulated in gastric adenocarcinoma.
Jakharia A; Borkakoty B; Singh S
J Gastrointest Oncol; 2016 Apr; 7(2):278-83. PubMed ID: 27034797
[TBL] [Abstract][Full Text] [Related]
11. Immunological role and prognostic value of SPARCL1 in pan-cancer analysis.
He K; Li C; Yuan H; Jiang K; Deng G
Pathol Oncol Res; 2022; 28():1610687. PubMed ID: 36483097
[No Abstract] [Full Text] [Related]
12. Clinicopathological significance of reduced SPARCL1 expression in human breast cancer.
Cao F; Wang K; Zhu R; Hu YW; Fang WZ; Ding HZ
Asian Pac J Cancer Prev; 2013; 14(1):195-200. PubMed ID: 23534723
[TBL] [Abstract][Full Text] [Related]
13. A prospective study on serum secreted protein acidic and rich in cysteine-like 1 as a prognostic marker for severe traumatic brain injury.
Huang HB; Yang SB; Shen LJ; Lv QW; Guo M; Zhou J; Li Z; Yang CS; Wang LY; Zhang H
Clin Chim Acta; 2019 Apr; 491():19-23. PubMed ID: 30639238
[TBL] [Abstract][Full Text] [Related]
14. SPARCL1 suppresses the proliferation and migration of human ovarian cancer cells via the MEK/ERK signaling.
Ma Y; Xu Y; Li L
Exp Ther Med; 2018 Oct; 16(4):3195-3201. PubMed ID: 30233672
[TBL] [Abstract][Full Text] [Related]
15. Methylation of SPARCL1 Is Associated with Oncologic Outcome of Advanced Upper Urinary Tract Urothelial Carcinoma.
Luo HL; Chiang PH; Huang CC; Su YL; Sung MT; Tsai EM; Lin CS; Chiang PH
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987093
[TBL] [Abstract][Full Text] [Related]
16. SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinoma.
Yu Y; Chen Y; Ma J; Yu X; Yu G; Li Z
Tumour Biol; 2016 Mar; 37(3):4159-67. PubMed ID: 26490986
[TBL] [Abstract][Full Text] [Related]
17. Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer.
Esposito I; Kayed H; Keleg S; Giese T; Sage EH; Schirmacher P; Friess H; Kleeff J
Neoplasia; 2007 Jan; 9(1):8-17. PubMed ID: 17325739
[TBL] [Abstract][Full Text] [Related]
18. The inhibition of HeLa cells proliferation through SPARCL1 mediated by SPP1.
Zhang S; Zhang F; Feng L
Cytotechnology; 2021 Feb; 73(1):71-78. PubMed ID: 33505115
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of dual specificity phosphatase 22 in colorectal cancer and its potential prognostic relevance for stage IV CRC patients.
Yu D; Li Z; Gan M; Zhang H; Yin X; Tang S; Wan L; Tian Y; Zhang S; Zhu Y; Lai M; Zhang D
Tumour Biol; 2015 Nov; 36(11):8531-5. PubMed ID: 26032091
[TBL] [Abstract][Full Text] [Related]
20. SPARCL1 Influences Bovine Skeletal Muscle-Derived Satellite Cell Migration and Differentiation through an ITGB1-Mediated Signaling Pathway.
Wang Y; Liu S; Yan Y; Li S; Tong H
Animals (Basel); 2020 Aug; 10(8):. PubMed ID: 32781616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
